Skip to main content

DiaMedica Therapeutics Inc.

For the period ended May 20, 2026. Filed Apr 1, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 20, 2026 · Filed Apr 1, 2026

DMAC$9.36+3.5%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Elements of Our Executive Compensation Program

During 2025, our executive compensation program consisted of several key elements, which are described in the table below, along with the key characteristics of, and the purpose for, each element and key 2025 changes.

ElementKey CharacteristicsPurposeKey 2025 Changes
Base Salary (Fixed, Cash)A fixed amount, paid in cash periodically throughout the year and reviewed annually and, if appropriate, adjusted.Provides source of fixed income that is market competitive and reflects scope and responsibility of the position held.Our CEO and CFO each received a base salary increase of 10%. Our CMO joined in August 2025 with an initial annual base salary of $525,000.
Short-Term Incentive (STI) (Variable, Cash)A variable, short-term element of compensation that is payable in cash based on achievement of key pre-established annual corporate objectives, and for certain executives, individual goals.Motivates and rewards our executives for achievement of annual corporate and other objectives.Target incentive payout for 2025 was 50% of base salary for CEO and 40% of base salary for CFO, both unchanged from last year. Target incentive payout for our new CMO was 40% of base salary.
Long-Term Incentives (LTI) (Variable, Equity-Based Awards)A variable, long-term element of compensation that is provided in the form of time-vested stock option awards.Aligns the interests of our executives with our shareholders; encourages our executives to focus on our long-term performance; promotes retention; and encourages significant share ownership.NEOs received stock option awards, with 25% vesting on one-year anniversary of grant date and remaining 75% vesting in 12 equal quarterly installments thereafter. The awards for our CEO and CFO were annual awards; whereas, the award for our CMO was a new hire award.
Retirement BenefitsA 401(k) plan with a discretionary company match.Provides an opportunity for employees to save and prepare financially for retirement.No changes.

We describe each key element of our executive compensation program in more detail in the following pages, along with the compensation decisions made in 2025. The compensation paid to our named executive officers is governed, in part, by written employment agreements with them, which are described below under “—Employment Agreements.” The named executive officers also have termination and change in control benefits as set forth in their respective employment agreements. See “—Post-Termination Severance and Change in Control Arrangements.”

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.